{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 6.422012, "regularMarketPrice": 1.16, "exchange": "FRA", "shortName": "NOVAN INC.  DL-,0001", "longName": "Novan, Inc.", "messageBoardId": "finmb_115977469", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683892036, "regularMarketDayHigh": 1.16, "regularMarketDayRange": "1.16 - 1.16", "regularMarketDayLow": 1.16, "regularMarketVolume": 3000, "regularMarketPreviousClose": 1.09, "bid": 1.14, "ask": 1.19, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.16, "averageDailyVolume3Month": 423, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.38949996, "fiftyTwoWeekLowChangePercent": 0.5055159, "fiftyTwoWeekRange": "0.7705 - 2.9655", "fiftyTwoWeekHighChange": -1.8055001, "fiftyTwoWeekHighChangePercent": -0.608835, "fiftyTwoWeekLow": 0.7705, "fiftyTwoWeekHigh": 2.9655, "earningsTimestamp": 1684153800, "earningsTimestampStart": 1684153800, "earningsTimestampEnd": 1684153800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.29, "epsForward": -1.34, "epsCurrentYear": -1.82, "priceEpsCurrentYear": -0.6373626, "sharesOutstanding": 28015400, "bookValue": 0.186, "fiftyDayAverage": 1.14189, "fiftyDayAverageChange": 0.018109918, "fiftyDayAverageChangePercent": 0.015859598, "twoHundredDayAverage": 1.4954175, "twoHundredDayAverageChange": -0.3354175, "twoHundredDayAverageChangePercent": -0.2242969, "marketCap": 33951228, "forwardPE": -0.8656716, "priceToBook": 6.236559, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1489993200000, "priceHint": 4, "regularMarketChange": 0.06999993, "symbol": "6LUA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4020 Stirrup Creek Drive", "address2": "Suite 110", "city": "Durham", "state": "NC", "zip": "27703", "country": "United States", "phone": "919 485 8080", "website": "https://www.novan.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Novan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina.", "fullTimeEmployees": 89, "companyOfficers": [{"maxAge": 1, "name": "Ms. Paula Brown Stafford M.P.H.", "age": 57, "title": "Pres, CEO & Chairwoman", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 623225, "fmt": "623.23k", "longFmt": "623,225"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John M. Gay CPA", "age": 45, "title": "CFO, Principal Accounting Officer & Corp. Sec.", "yearBorn": 1977, "fiscalYear": 2022, "totalPay": {"raw": 386895, "fmt": "386.89k", "longFmt": "386,895"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John A. Donofrio Jr.", "age": 55, "title": "Exec. VP & COO", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 602513, "fmt": "602.51k", "longFmt": "602,513"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Carri  Geer Ph.D.", "title": "Sr. VP & CTO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Brian M. Johnson", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1966, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tomoko  Maeda-Chubachi M.B.A., M.D., Ph.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}